Figure 3From: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients ROC curves analyzing the use of expression levels of individual genes, CCNB1, CDC20 and CDKN3, to accurately assign patients to prognostic groups.Back to article page